| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA860090 | F | Antiproliferative activity against human MeWo cells | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 2. | ALA1794513 | F | PUBCHEM_BIOASSAY: Counterscreen of A1 inhibitors in unprimed human MEWO cells Measured in Cell-Based System Using Plate Reader - 2045-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2526] | Homo sapiens | ⋯ | cell-based format | PubChem BioAssays | ||
| 3. | ALA1794558 | F | PUBCHEM_BIOASSAY: Secondary assay of A1 inhibitors in Trichostatin A primed human MEWO cells Measured in Cell-Based System Using Plate Reader - 2045-07_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2526] | Homo sapiens | 4 | cell-based format | PubChem BioAssays | ||
| 4. | ALA979708 | F | Cytotoxicity against human MEWO cells assessed as fraction of viable cells after 72 hrs relative to control | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
| 5. | ALA1777357 | F | Cytotoxicity against human MeWo cells assessed as cell growth inhibition at 5 to 10 uM after 72 hrs by MTT assay | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 6. | ALA1777425 | F | Antiproliferative activity against human MeWo cells expressing wild type b-Raf | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 7. | ALA2338928 | A | Cytotoxicity against human MeWo cells after 72 hrs by crystal violet staining method | Homo sapiens | 7 | cell-based format | Scientific Literature | ||
| 8. | ALA2363448 | F | SANGER: Inhibition of human Mewo cell growth in a cell viability assay. | Homo sapiens | 98 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | ||
| 9. | ALA2416154 | F | Antitubulinic activity in human MeWo cells assessed as blockade in G2/M phase at 3 X IC50 after 16 hrs by propidium iodide staining-based FACS analysis | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
| 10. | ALA2416156 | F | Cytotoxicity against human MeWo cells assessed as cell viability after 48 hrs by MTT assay | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
| 11. | ALA2416157 | F | Cytotoxicity against human MeWo cells assessed as cell viability at 10 uM after 48 hrs by MTT assay relative to vehicle-treated control | Homo sapiens | 32 | cell-based format | Scientific Literature | ||
| 12. | ALA3384254 | F | Cytotoxicity against human MeWo cells at 1.6 to 100 ug/ml after 72 hrs by crystal violet assay | Homo sapiens | 34 | cell-based format | Scientific Literature | ||
| 13. | ALA3607872 | F | Cytotoxicity against human MeWo cells after 48 hrs by CellTiter-Blue assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 14. | ALA3607878 | F | Inhibition of cell migration in human MeWo cells assessed as gap closure distance at 5 uM after 24 hrs by wound healing assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 15. | ALA3607882 | F | Inhibition of cell migration in human MeWo cells assessed as gap closure distance at 5 uM after 24 hrs by wound healing assay in presence of 1 uM of LPA | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 16. | ALA3607883 | F | Cytotoxicity against human MeWo cells assessed as reduction of cell viability after 48 hrs by CellTiter-Blue assay | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 17. | ALA3608190 | F | Antitumor activity against human MeWo cells xenografted in athymic nude mouse assessed as reduction of KC/CXCL-1 level in serum at 50 mg/kg, ip administered every other day of 21 days post tumor cell injection | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 18. | ALA3608191 | F | Antitumor activity against human MeWo cells xenografted in athymic nude mouse assessed as necrosis in tumor at 50 mg/kg, ip administered every other day of 21 days post tumor cell injection up to 48 days followed by administered 40 mg/kg, ip using hematoxylin and eosin staining | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 19. | ALA3608192 | F | Antitumor activity against human MeWo cells xenografted in athymic nude mouse assessed as necrotic endothelial cells at 50 mg/kg, ip administered every other day of 21 days post tumor cell injection up to 48 days followed by administered 40 mg/kg, ip using hematoxylin and eosin staining | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 20. | ALA3608193 | F | Antitumor activity against human MeWo cells xenografted in athymic nude mouse assessed as reduction of ATX level in serum at 50 mg/kg, ip administered every other day of 21 days post tumor cell injection | Homo sapiens | 1 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!